Calls 2021-2022 – Pillar II – Cluster 1 ‘’HEALTH’’

DL: 21/09/2021 - Closing date for the first calls of cluster 1 - Health

Pillar II Global Challenges and European Industrial Competitiveness, supports research relating to societal challenges and reinforces technological and industrial capacities through six Clusters.

Cluster 1 - Health: Work Programme 2021-2022

  • Projects require to build consortia with participants from at least 3 different Member states or Associate countries.
  • Cluster 1 - Six Destinations (Outcomes) :
    • Staying healthy in a rapidly changing society
    • Living and working in a health-promoting environment
    • Tackling diseases and reducing disease burden
    • Ensuring access to innovative, sustainable and high-quality health care
    • Unlocking the full potential of new tools, technologies and digital solutions for a healthy society
    • Maintaining an innovative, sustainable and globally competitive health industry
  • Please see below the topics links
  • 1st Deadline: 21/09/2021, 17:00 Brussels time

Mission CANCER: 1st call: DL 20/10/2021

Destination 1 – Staying healthy in a rapidly changing society

Deadline

17:00 CEST

HORIZON-HLTH-2021-STAYHLTH-01-02: Towards a molecular and neurobiological understanding of mental health and mental illness for the benefit of citizens and patients

21/09/2021

HORIZON-HLTH-2021-STAYHLTH-01-03: Healthy Citizens 2.0 - Supporting digital empowerment and health literacy of citizens

21/09/2021

HORIZON-HLTH-2021-STAYHLTH-01-04: A roadmap for personalised prevention

21/09/2021

Destination 2 – Living and working in a health-promoting environment

HORIZON-HLTH-2021-ENVHLTH-02-01: Exposure to electromagnetic fields (EMF) and health

21/09/2021

HORIZON-HLTH-2021-ENVHLTH-02-02: Indoor air quality and health

21/09/2021

HORIZON-HLTH-2021-ENVHLTH-02-03: Health impacts of climate change, costs and benefits of action and inaction

21/09/2021

Destination 3 – Tackling diseases and reducing disease burden

HORIZON-HLTH-2021-DISEASE-04-01: Improved supportive, palliative, survivorship and end-of-life care of cancer patients

21/09/2021

HORIZON-HLTH-2021-DISEASE-04-02: Building a European innovation platform for the repurposing of medicinal products

21/09/2021

HORIZON-HLTH-2021-DISEASE-04-03: Innovative approaches to enhance poverty-related diseases research in sub-Saharan Africa

21/09/2021

HORIZON-HLTH-2021-DISEASE-04-04: Clinical validation of artificial intelligence (AI) solutions for treatment and care

21/09/2021

HORIZON-HLTH-2021-DISEASE-04-07: Personalised medicine and infectious diseases: understanding the individual host response to viruses (e.g. SARS-CoV-2)

21/09/2021

HORIZON-HLTH-2021-DISEASE-04-05: A roadmap towards the creation of the European partnership on One Health antimicrobial resistance (OH AMR)

21/09/2021

HORIZON-HLTH-2021-DISEASE-04-06: Building a European partnership for pandemic preparedness

21/09/2021

Destination 4 – Ensuring access to innovative, sustainable and high-quality health care

HORIZON-HLTH-2021-CARE-05-01: Enhancing quality of care and patient safety

21/09/2021

HORIZON-HLTH-2021-CARE-05-02: Data-driven decision-support tools for better health care delivery and policy-making with a focus on cancer

21/09/2021

Destination 5 – Unlocking the full potential of new tools, technologies and digital solutions for a healthy society

HORIZON-HLTH-2021-TOOL-06-01: Smart medical devices and their surgical implantation for use in resource-constrained settings

21/09/2021

HORIZON-HLTH-2021-TOOL-06-02: Next generation advanced therapies to treat highly prevalent and high burden diseases with unmet medical needs

21/09/2021

HORIZON-HLTH-2021-TOOL-06-03: Innovative tools for use and re-use of health data (in particular of electronic health records and/or patient registries)

21/09/2021

Destination 6 – Maintaining an innovative, sustainable and globally competitive health industry

HORIZON-HLTH-2021-IND-07-01: Green pharmaceuticals

21/09/2021

HORIZON-HLTH-2021-IND-07-02: Development, procurement and responsible management of new antimicrobials

21/09/2021

HORIZON-HLTH-2021-IND-07-03: Promoting a trusted mHealth label in Europe: uptake of technical specifications for quality and reliability of health and wellness apps

21/09/2021

MISSION – CANCER

HORIZON-MISS-2021-UNCAN-01-01: Preparing UNCAN.eu, a European initiative to understand cancer

20/10/2021

Contact to UCLouvain Research Administration
Mrs Mahdia Abdelouahab (ADRE/RINT) - Phone: +32 (0)10/47.24.80

 

The SMCS (UCLouvain's statistical support platform - Support request) is also at your disposal for any questions regarding the collection and analysis of your data.

 

Publié le 29 juin 2021